Literature DB >> 6149491

A comparison of temazepam and flurazepam in terms of sleep quality and residual changes in performance.

K Wesnes, D M Warburton.   

Abstract

This study compared the effects of single nightly doses of flurazepam 30 mg and temazepam 40 mg upon both the subjective assessment of sleep quality and performance on 3 tests of mental efficiency 10 h following medication. 12 male and 12 female non-smoker subjects took part, none of whom experienced sleep difficulties. In comparison with their respective placebos, both hypnotics produced marked and significant improvements in the quality, depth and duration of sleep, and reduced the difficulty that the female subjects experienced in getting to sleep. Flurazepam also produced a significant increase in satisfaction with sleep together with significant reductions in the number of awakenings during the night and the level of clearheadedness on waking. The major test of performance was a continuous 20-min rapid visual information processing task. It was found that for both sexes during each of the two consecutive 10-min periods of performance flurazepam produced highly significant residual impairments in both the speed of reaction and the accuracy of detection, while temazepam had no effect. Overall the results indicate that flurazepam produces a wider range of improvements in sleep quality than temazepam at the cost of less clearheadedness on waking and residual impairments in sustained rapid information processing.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6149491     DOI: 10.1159/000118090

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


  3 in total

Review 1.  Benzodiazepines and vigilance performance: a review.

Authors:  H S Koelega
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

2.  The value of assessing cognitive function in drug development.

Authors:  K A Wesnes
Journal:  Dialogues Clin Neurosci       Date:  2000-09       Impact factor: 5.986

3.  Randomized, Placebo-Controlled, Double-Blind Pilot Study of D-Cycloserine in Chronic Stroke.

Authors:  Andrew J Butler; Justiss Kallos; Stephen N Housley; Michelle C LaPlaca; Stephen F Traynelis; Steven L Wolf
Journal:  Rehabil Res Pract       Date:  2015-10-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.